210 related articles for article (PubMed ID: 8198710)
1. Superantigens and retroviral infection: insights from mouse mammary tumor virus.
Held W; Acha-Orbea H; MacDonald HR; Waanders GA
Immunol Today; 1994 Apr; 15(4):184-90. PubMed ID: 8198710
[TBL] [Abstract][Full Text] [Related]
2. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-host interactions. The mouse mammary tumor virus model.
Acha-Orbea H
Medicina (B Aires); 1997; 57 Suppl 2():43-52. PubMed ID: 9567343
[TBL] [Abstract][Full Text] [Related]
4. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
5. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
6. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
7. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
[TBL] [Abstract][Full Text] [Related]
8. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
[TBL] [Abstract][Full Text] [Related]
9. Subversion of host immune responses by viral superantigens.
Acha-Orbea H; MacDonald HR
Trends Microbiol; 1993 Apr; 1(1):32-4. PubMed ID: 8143113
[TBL] [Abstract][Full Text] [Related]
10. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
11. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus.
Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410
[TBL] [Abstract][Full Text] [Related]
12. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
[TBL] [Abstract][Full Text] [Related]
13. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
14. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
15. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
16. Immune response to mouse mammary tumour virus.
Luther SA; Acha-Orbea H
Curr Opin Immunol; 1996 Aug; 8(4):498-502. PubMed ID: 8794013
[TBL] [Abstract][Full Text] [Related]
17. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
18. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
19. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.
Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT
J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931
[TBL] [Abstract][Full Text] [Related]
20. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
